Kemball-Cook G, Barrowcliffe T W
Br J Haematol. 1984 Aug;57(4):633-6. doi: 10.1111/j.1365-2141.1984.tb02940.x.
Labelled Fab' fragments, derived from the plasma of a severe haemophiliac with antibody directed against factor VIII clotting antigen (VIII C:Ag), were fractionated by immunoabsorption with, first, a complex of phospholipid (PL) vesicles and factor VIII and, second, with factor VIII alone. Two pools of labelled anti-VIII C:Ag were obtained and were used in immunoradiometric assays (IRMAs) for VIII C:Ag. With one pool (non-PL-site antibody) VIII C:Ag assays were unaffected by pre-incubation of factor VIII with PL vesicles; however, binding of the second pool of antibody to VIII C:Ag was prevented by PL preincubation, indicating that these antibody molecules bind at or near a phospholipid binding site on VIII C:Ag (PL-site antibody). Assays of VIII C:Ag in an intermediate purity factor VIII concentrate with these two antibody pools indicate that more than one third of the VIII C:Ag may be bound to PL.
从一名患有针对凝血因子VIII凝血抗原(VIII C:Ag)抗体的严重血友病患者血浆中获得的标记Fab'片段,首先通过与磷脂(PL)囊泡和凝血因子VIII的复合物进行免疫吸收,然后仅与凝血因子VIII进行免疫吸收,从而进行分离。获得了两池标记的抗VIII C:Ag,并将其用于VIII C:Ag的免疫放射分析(IRMA)。对于其中一池(非PL位点抗体),VIII C:Ag分析不受凝血因子VIII与PL囊泡预孵育的影响;然而,PL预孵育会阻止第二池抗体与VIII C:Ag的结合,这表明这些抗体分子在VIII C:Ag上的磷脂结合位点或其附近结合(PL位点抗体)。用这两池抗体对中间纯度的凝血因子VIII浓缩物中的VIII C:Ag进行分析表明,超过三分之一的VIII C:Ag可能与PL结合。